Catalysts for Aurobindo Pharma Ltd
350 tracked
Apr 20, 2026
approval
PIRFENIDONE โ FDA approval
PIRFENIDONE
โ
Apr 20, 2026
approval
CANAGLIFLOZIN โ FDA approval
CANAGLIFLOZIN
โ
Apr 15, 2026
approval
DEXTROMETHORPHAN POLISTIREX โ FDA approval
DEXTROMETHORPHAN POLISTIREX
โ
Apr 15, 2026
approval
GLYCEROL PHENYLBUTYRATE โ FDA approval
GLYCEROL PHENYLBUTYRATE
โ
Apr 15, 2026
approval
ALENDRONATE SODIUM โ FDA approval
ALENDRONATE SODIUM
โ
Apr 9, 2026
approval
LAMOTRIGINE โ FDA approval
LAMOTRIGINE
โ
Apr 9, 2026
approval
LAMOTRIGINE โ FDA approval
LAMOTRIGINE
โ
Apr 6, 2026
approval
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE) โ FDA approval
DAPAGLIFLOZIN
โ
Apr 6, 2026
approval
DAPAGLIFLOZIN โ FDA approval
DAPAGLIFLOZIN
โ
Mar 24, 2026
approval
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (BISOPROLOL FUMARATE) โ FDA approval
Aurobindo Pharma Ltd
โ
Mar 23, 2026
approval
CINACALCET HYDROCHLORIDE โ FDA approval
CINACALCET HYDROCHLORIDE
โ
Mar 23, 2026
approval
CEFIXIME โ FDA approval
CEFIXIME
โ
Mar 18, 2026
approval
VIGABATRIN โ FDA approval
VIGABATRIN
โ
Mar 18, 2026
approval
CLINDAMYCIN PHOSPHATE โ FDA approval
CLEOCIN
โ
Mar 18, 2026
approval
VIGABATRIN โ FDA approval
VIGABATRIN
โ
Mar 18, 2026
approval
MYCOPHENOLATE MOFETIL โ FDA approval
MYCOPHENOLATE MOFETIL
โ
Mar 13, 2026
approval
CITALOPRAM HYDROBROMIDE โ FDA approval
CITALOPRAM HYDROBROMIDE
โ
Mar 6, 2026
approval
SIPONIMOD โ FDA approval
SIPONIMOD
โ
Mar 2, 2026
approval
ONDANSETRON HYDROCHLORIDE โ FDA approval
ondansetron hydrochloride CR
โ
Feb 24, 2026
approval
FINGOLIMOD HYDROCHLORIDE โ FDA approval
FINGOLIMOD HYDROCHLORIDE
โ
Feb 18, 2026
approval
ARIPIPRAZOLE โ FDA approval
aripiprazole LA
โ
Feb 15, 2026
approval
AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) โ FDA approval
amoxicillin
โ
Feb 9, 2026
approval
ISOTRETINOIN โ FDA approval
ISOTRETINOIN
โ
Feb 3, 2026
approval
IBANDRONATE SODIUM โ FDA approval
IBANDRONATE SODIUM
โ
Jan 26, 2026
approval
BETAMETHASONE DIPROPIONATE โ FDA approval
BETAMETHASONE DIPROPIONATE
โ
Jan 21, 2026
approval
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (BISOPROLOL FUMARATE) โ FDA approval
BISOPROLOL FUMARATE
โ
Jan 15, 2026
approval
FLUOXETINE HYDROCHLORIDE โ FDA approval
FLUOXETINE HYDROCHLORIDE
โ
Jan 15, 2026
approval
FLUOXETINE HYDROCHLORIDE โ FDA approval
FLUOXETINE HYDROCHLORIDE
โ
Jan 14, 2026
approval
MYCOPHENOLATE SODIUM โ FDA approval
mycophenolate sodium DR
โ
Jan 14, 2026
approval
MYCOPHENOLATE MOFETIL โ FDA approval
MYCOPHENOLATE MOFETIL
โ